Bradykinin Type 1 Receptor – Inducible Nitric Oxide Synthase: A New Axis Implicated in Diabetic Retinopathy

Compelling evidence suggests a role for the inducible nitric oxide synthase, iNOS, and the bradykinin type 1 receptor (B1R) in diabetic retinopathy, including a possible control of the expression and activity of iNOS by B1R. In diabetic retina, both iNOS and B1R contribute to inflammation, oxidative...

Descripción completa

Detalles Bibliográficos
Autores principales: Othman, Rahmeh, Vaucher, Elvire, Couture, Réjean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449803/
https://www.ncbi.nlm.nih.gov/pubmed/30983997
http://dx.doi.org/10.3389/fphar.2019.00300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449803/
https://www.ncbi.nlm.nih.gov/pubmed/30983997
http://dx.doi.org/10.3389/fphar.2019.00300

Ejemplares similares